ID: ALA4645223

Max Phase: Preclinical

Molecular Formula: C31H30F2N4O5S

Molecular Weight: 608.67

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CC(=O)NCCOc1cc(C(OCCS(C)(=O)=O)c2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12

Standard InChI:  InChI=1S/C31H30F2N4O5S/c1-3-28(38)34-11-12-41-27-17-21(30(19-7-5-4-6-8-19)42-13-14-43(2,39)40)16-24-23(27)18-26(35-24)29-22-10-9-20(31(32)33)15-25(22)36-37-29/h3-10,15-18,30-31,35H,1,11-14H2,2H3,(H,34,38)(H,36,37)

Standard InChI Key:  XRXVQPNHFLSJCG-UHFFFAOYSA-N

Associated Targets(Human)

Tyrosine-protein kinase ITK/TSK 3699 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase BTK 8973 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 608.67Molecular Weight (Monoisotopic): 608.1905AlogP: 5.48#Rotatable Bonds: 13
Polar Surface Area: 126.17Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.36CX Basic pKa: 1.53CX LogP: 3.70CX LogD: 3.70
Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.12Np Likeness Score: -0.76

References

1. Wang X, Xue G, Pan Z..  (2020)  Design, synthesis and structure-activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK).,  187  [PMID:31830635] [10.1016/j.ejmech.2019.111918]

Source